Partners Innovation Fund

About The Fund

Established in 2007 by Brigham and Women's Hospital and Massachusetts General Hospital, the Partners Innovation Fund (PIF) aims to transform healthcare by accelerating innovative technologies from idea to market. With a capital commitment of $35M and an evergreen structure, the fund feeds gains back into its pool for continued reinvestment in new projects. The PIF invests primarily in BioTech, Medical Devices (& Hospital Services), DeepTech, and Healthcare (& Wellness), focusing on early, seed, Series A, and later-stage opportunities. They target investments with a minimum of $7,500,000 and a maximum of $63,812,231. Their portfolio reflects their dedication to bridging the capital gap between invention and clinical development, targeting opportunities that larger investors might overlook due to their early stage. The fund is managed as a separate LLC and adheres to a venture capital model, employing stringent scientific and commercial viability evaluations. They distribute funds in two forms: equity investments to spur company formation and development investments for pre-company technology validation with commercial potential. The PIF assessment process involves initial screening and extensive due diligence, taking 3 to 6 months and culminating in approval by an independent external committee. Post-investment, they provide comprehensive support, including helping to establish the venture, appointing management, advising on technology development, and engaging with stakeholders to achieve pivotal milestones. The infusion of institutional commitment from Partners HealthCare through PIF bolsters the confidence of co-investors, aiming to leverage and encourage joint investments and ultimately generate a sustainable return.